Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant Melanoma
Mayinuer Maitituoheti(The University of Texas MD Anderson Cancer Center), Kunal Rai(The University of Texas MD Anderson Cancer Center), Ayush T. Raman(National Institutes of Health), Edward Chang(The University of Texas MD Anderson Cancer Center), Davis R. Ingram(The University of Texas MD Anderson Cancer Center), Elias Orouji(The University of Texas MD Anderson Cancer Center), Mayura Dhamdhere(University of Pennsylvania), Norman Zheng(The University of Texas MD Anderson Cancer Center), Sharmistha Sarkar(The University of Texas MD Anderson Cancer Center), Sneha Sharma(The University of Texas MD Anderson Cancer Center), Guangchun Han(The University of Texas MD Anderson Cancer Center), Christopher Terranova(The University of Texas MD Anderson Cancer Center), Alexander J. Lazar(The University of Texas MD Anderson Cancer Center), Neha S. Samant(The University of Texas MD Anderson Cancer Center), Linghua Wang(The University of Texas MD Anderson Cancer Center), Amiksha Shah(The University of Texas MD Anderson Cancer Center), Maura Williams(The University of Texas MD Anderson Cancer Center), Yu-Hsi Lin(Boehringer Ingelheim (Brazil)), Wei‐Lien Wang(The University of Texas MD Anderson Cancer Center), Haoqiang Ying(The University of Texas MD Anderson Cancer Center), Nazanin Esmaeili Anvar(The University of Texas MD Anderson Cancer Center), Emily Z. Keung(The University of Texas MD Anderson Cancer Center), Yan Liang(Qingdao University), Jacob B. Axelrad(The University of Texas MD Anderson Cancer Center), Florian L. Müller(nLIGHT (United States)), Shan Jiang(Hubei University of Medicine), Ming Tang(Shanghai First Maternity and Infant Hospital), Min Gyu Lee(The University of Texas MD Anderson Cancer Center), Tara Shah(The University of Texas MD Anderson Cancer Center), Hunain Alam(The University of Texas MD Anderson Cancer Center)
Cited by 2
Related Papers
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
|Cell|2018|4k
Oncogenic Signaling Pathways in The Cancer Genome Atlas
|Cell|2018|3.4k